Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Prostate Cancer
Would you offer modest hypofractionation (e.g. 70 Gy/28 fractions) to a patient with intermediate risk prostate cancer and celiac disease?
Answer from: Radiation Oncologist at Community Practice
Celiac disease is primary small bowel disease. RT effect on rectum would not be exaggerated from the disease.
Sign in or Register to read more
5901
Related Questions
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
In asymptomatic patients with castrate resistant prostate cancer who have failed chemotherapy and have progressive vertebral body metastases, when do you prescribe lutetium-177 vs prophylactic spinal radiation?
Would you offer adjuvant XRT to the prostate fossa in a patient with Lynch Syndrome?
Does a negative staging PSMA PET in a patient with biopsy-proven recurrent prostatic adenocarcinoma change your management?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?
Which patients with prostate cancer do you consider to be good candidates for salvage local treatment after radiation therapy?
Would you ever omit or reduce prostate bed radiation in a post-prostatectomy patient who develops recurrence in pelvic LNs?
Do you offer prostate RT to men with 0-3 bone metastases on conventional imaging when PSMA PET shows a very high number of M1 lesions?
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
How would you plan sequencing of an MRI-directed prostate nodule micro-boost when doing a sequential plan?